Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy
Abstract Programmed Death Receptor-1 (PD-1) is an immune checkpoint receptor expressed on the surface of T cells. Monoclonal antibodies targeting PD-1 and its ligand, PD-L1, are among the most widely utilized immune checkpoint inhibitors in cancer immunotherapy, dramatically improving the prognosis...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer
2025-05-01
|
| Σειρά: | Discover Oncology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1007/s12672-025-02596-y |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|